AzTrials
AzTrials

Neurodevelopmental DisordersNCT07503106

The Relationship Between Reaction Time and Motor Skills in Children With Pervasive Developmental Disorders

An observational study of Neurodevelopmental Disorders, run by Yeditepe University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study examines whether the relationship between reaction time and motor skills differs between children aged 3-6 with pervasive developmental disorders and typically developing peers. Read more about this study

Who is it for?
Ages 3 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Neurodevelopmental Disorders
What is being tested?
Peabody Developmental Motor Scales
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
Apr 2026to Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: In this study, the sample will be selected using a purposive sampling method from children aged 3-6 years who meet the predefined inclusion and exclusion criteria.

Who may be able to join

  • Being between 3 and 6 years of age
  • For typically developing children, having no diagnosis of any neurodevelopmental or orthopedic disorder
  • Having a diagnosis of Pervasive Developmental Disorder made by a child psychiatrist or pediatric neurologist
  • Absence of visual, auditory, or motor impairments that would prevent administration of the Peabody Developmental Motor Scales-2 (PDMS-2) and the Catch Pad reaction test
  • Having sufficient cognitive ability to understand and follow simple instructions during the assessment

Who cannot join

  • In the typically developing group, having a diagnosis of Attention Deficit -Hyperactivity Disorder (ADHD) or any other neurodevelopmental disorder
  • Presence of additional neurological or orthopedic conditions, apart from Pervasive Developmental Disorder, that would interfere with test administration
  • Visual or hearing impairments severe enough to prevent test administration
  • History of orthopedic trauma or surgery within the last 6 months that could affect motor performance
  • Presence of significant behavioral problems

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Özel Altan Akademi Rehabilitasyon Merkezi

    Başakşehir, Istanbul

    Sinem Sude Koç, PT, 05364658278, sinemsude.koc@std.yeditepe.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Relationship Between Reaction Time and Motor Skills in Preschool Children With Pervasive Developmental Disorders

This study examines whether the relationship between reaction time and motor skills differs between children aged 3-6 with pervasive developmental disorders and typically developing peers. It aims to determine the direction and strength of this relationship in children with developmental disorders and compare it with that of typically developing children, thereby providing evidence on how cognitive processing speed and motor performance interact in early childhood under developmental disorder conditions.

Read the detailed description

This study is designed as a descriptive and comparative investigation aimed at examining differences in motor skills and reaction times between children aged 3-6 diagnosed with pervasive developmental disorders and their typically developing peers. The sample consists of 15 children with pervasive developmental disorders attending special education and rehabilitation centers and 15 typically developing children from the same age group.

No training or intervention program will be implemented; data will be collected through single-session, one-time assessments. To comprehensively evaluate motor skills, the Peabody Developmental Motor Scales-Second Edition (PDMS-2), widely regarded as a gold standard in child development assessment, will be used. In addition, participants' reaction times will be measured using the reaction test module of the Catch Pad application, a digital tool frequently utilized in scientific research.In this way, performance components including both general motor skills and response speed will be objectively measured, and differences between the two groups will be scientifically identified.

Being tested
Peabody Developmental Motor Scales
Keywords
Reaction time, Peabody Developmental Motor Scales, Pervasive Developmental Disorders
Medical subject headings
Neurodevelopmental Disorders, Child Development Disorders, Pervasive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Peabody Developmental Motor ScalesOther

    Motor skills will be assessed using the Peabody Developmental Motor Scales-Second Edition (PDMS-2), a standardized and validated tool measuring gross and fine motor performance. Subtests will be administered face-to-face in an age-appropriate manner and scored according to the manual.

Study groups in NCT07503106
Study groupRoleWhat they receive
Pervasive Developmental Disorders GroupFifteen children aged between 3 and 6 years who have been diagnosed with pervasive developmental disorders.
Receives: Other: Peabody Developmental Motor Scales
Typically Developing Peers GroupFifteen children aged between 3 and 6 years who have been typically developing peers
Receives: Other: Peabody Developmental Motor Scales

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peabody Developmental Motor Scales

    Reflexes, locomotor skills, object control, grasping, and visual-motor integration will be evaluated by this test

    Measured: One day

  2. Simple Reaction Time Test

    Reaction time will be evaluated by this test

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07503106
Sponsor's protocol ID
SinemK
Status last verified
Apr 2026
First submitted
25 Mar 2026
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Neurodevelopmental Disorders, run by Yeditepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peabody Developmental Motor Scales (time frame: One day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in